Prospective and Multicentric Validation of the ArgenSCORE in Aortic Valve Replacement Surgery. Comparison with the EuroSCORE I and the EuroSCORE II

pp. 6-12

Authors

  • Victorio C. Carosella Instituto FLENI, CABA, Argentina
  • Christian Mastantuono Sanatorio Dr. Julio Méndez, CABA, Argentina
  • Valeria Golovonevsky Sanatorio Dr. Julio Méndez, CABA, Argentina
  • Valeria Cohen Sanatorio Dr. Julio Méndez, CABA, Argentina
  • Hugo Grancelli Instituto FLENI, CABA, Argentina
  • Walter Rodríguez Instituto FLENI, CABA, Argentina; Sanatorio de la Trinidad, CABA, Argentina; Sanatorio de los Arcos, CABA, Argentina

DOI:

https://doi.org/10.7775/rac.v82i1.1819

Keywords:

Cardiovascular Surgical Procedures, Risk Assessment, Mortality

Abstract

Introduction
In patients with aortic stenosis and planned aortic valve replacement, an accurate stratification of surgical risk is mandatory to offer the best individual option. Preoperative risk scores have recovered a leading role in the assessment of these patients.
Objectives
The aim of this study was to perform a prospective, multicentric validation of the ArgenSCORE and compare its performance with the EuroSCORE I and the EuroSCORE II. 
Methods
A total of 250 adult patients undergoing aortic valve replacement at four centers of the City of Buenos Aires were included in the study from February 2008 to December 2012. The ArgenSCORE was compared with the EuroSCORE I and the EuroSCORE II, evaluating model discrimination with the area under the ROC curve and calibration comparing the relation between observed mortality and predicted mortality.

Results
The mean age of the validation population (n = 250) was 68.62 ± 13.3 years and overall mortality of 3.6%. The ArgenSCORE showed good discrimination power (area under the ROC curve of 0.82) and a good predictive capacity to allocate risk (relation between observed mortality: 3.6% vs. predicted mortality: 3.39%; p = 0.471). The EuroSCORE I showed poor discrimination power (area under the ROC curve of 0.62) and risk overestimation (relation between observed mortality: 3.6% vs. predicted mortality: 5.58%; p < 0.0001). The EuroSCORE II showed an acceptable discrimination power (area under the ROC curve of 0.76), though lower than that of the ArgenSCORE, but a significant underestimation of predicted risk (relation between observed mortality: 3.6% vs. predicted mortality:1.64%; p < 0.0001).
Conclusions
The ArgenSCORE evidenced adequate ability to predict mortality in patients undergoing AVR surgery. This local model demonstrated good discrimination power and better calibration compared to the European models, as the EuroSCORE I overestimated and the EuroSCORE II underestimated predicted risk.

Downloads

Published

2025-10-14

Issue

Section

ORIGINAL ARTICLES

Most read articles by the same author(s)

1 2 3 4 > >>